About us.
Company overview.
SSP Co., Ltd. is a pharmaceutical company specializing in OTC (over-the-counter) drugs and healthcare products, providing a wide range of products to meet health needs for over 250 years since its establishment in 1765.
In 2017, SSP became a part of Sanofi, a global healthcare leader headquartered in Paris, France. SSP operated as a part of Sanofi’s consumer healthcare division, Opella. In 2025, Opella became an independent CHC company owned by CD&R, a global private equity. Opella is one of the top three consumer healthcare companies in the world with products sold in more than 140 countries. At SSP, we aim to bring together Opella’s global expertise, scale, and international ways of working with a deep knowledge of our consumers in Japan.
While SSP enjoys broad consumer support through its antipyretic analgesic “EVE”, allergy medication “Alesion”, L-cysteine vitamin “Hythiol”, and sleep-improving drug “Drewell”, the company will continue to contribute to improving people's health and quality of life through the development of high value-added pharmaceuticals such as “Switch OTC drugs” and the promotion of self-medication. For more information on SSP, please visit https://www.ssp.co.jp/.
Highlights.
- Top market share in the categories of antipyretic analgesics*1, oral rhinitis drugs*1, and hypnotic sedatives*2 in Japan
- First to market ibuprofen (an ingredient used as an antipyretic and analgesic), L-cysteine (a type of amino acid that normalizes turnover) and epinastine hydrochloride (a second-generation antihistamine ingredient) as OTC drugs in Japan
- Track record of original developments, including the “Quick Action Formulation*3”, a proprietary formulation that is fast-acting for headaches, and OTC sleep-improving drugs*4 that utilize ingredients that induce drowsiness
- Intege SRI+ Antipyretic analgesic market and rhinitis treatment “Rhinitis agent” market, respectively Joly 2022 - June 2023 Value Share
- Intege SRI+ Hypnotic sedatives market Dec. 2021-Jun. 2023 Value Share
- A proprietary manufacturing method of SSP that stably combines the analgesic ingredient ibuprofen with magnesium oxide, which speeds up the absorption of the analgesic ingredient, to achieve rapid elution and absorption of ibuprofen.
- The first OTC sleep-improving drug in Japan, focusing on the fact that antihistamine (diphenhydramine hydrochloride) suppresses allergic effects but also induces drowsiness.
Company information.
| Company name | SSP Co., Ltd. |
|---|---|
| Headquarters | Tokyo Opera City Tower, 3-20-2 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1444 |
| President | Nikhilesh Kalra |
| Business | Manufacture and sale of OTC dugs, food products, etc. |
| Founding | 1765 |
| Establishment | 1927 |
| Shareholder | Opella Healthcare Group SAS (100%) |
| TEL | ＋81-3-6301-4511 |
Access to
headquarters.
Traffic access
Keio New Line:1 minute walk from Hatsudai Station Inside Tokyo Opera City Tower
List of Offices and Plants.
- Narita Plant1143 Nanpeidai, Narita-shi, Chiba 286-8511
- East Japan Distribution Center1778-5, Nishihara, Shimotsuboyama, Shimono-shi, Tochigi 323-0115
- North Japan (Hokkaido) Distribution CenterInside the Ishikari office, 2-767 Shinko Nishi, Ishikari, Hokkaido 061-3241, Japan
- West Japan Osaka Distribution Center5-6-18 Torikai Honmachi, Settsu City, Osaka 566-0052, Japan
- Kyushu Distribution Center5-1-34 Hakozaki-futo, Higashi-ku, Fukuoka-shi, Fukuoka 812-0051
Policy on Customer Harassment.
Introduction
At SS Pharmaceutical, we are committed to the mission of the Opera Group, "Health. In your hands." We strive to make healthcare accessible and manageable, enabling consumers to practice self-care and lead healthy lives.
To achieve this, we value our relationships with customers, business partners, and consumers (hereinafter referred to as "customers"). We also respect the human rights of both our employees and customers, ensuring a safe working environment where employees can perform their duties with peace of mind. To build further trust with our customers, we have established this "Policy on Customer Harassment."
Basic Policy
We treat the opinions and requests from our customers as valuable information for improving our products and services. We respond sincerely and aim to provide higher quality products and services.
However, if customer demands or behaviors are deemed significantly inappropriate by societal standards, they may harm the dignity of SS Pharmaceutical employees or those engaged in our business, and adversely affect their working environment.
To ensure the safety and health of our employees, we will respond firmly to demands or behaviors that constitute customer harassment while maintaining sincerity in our interactions with customers.
Definition of Customer Harassment
Customer harassment refers to demands or behaviors from customers that are significantly unreasonable by societal standards and harm the working environment of our employees. Examples of behaviors considered as customer harassment include:
- Physical or mental attacks
- Intimidating behavior
- Forcing unreasonable apologies or bowing
- Unreasonable or excessive demands
- Persistent or continuous behavior
- Restrictive actions
- Discriminatory remarks
- Attacks or harassment towards individual employees, invasion of privacy
- Sexual remarks
Response to Customer Harassment
While we aim for reasonable and rational solutions, if we determine that certain behaviors constitute customer harassment, we may cease our response. In cases where demands or behaviors are deemed malicious, we will consult with external experts such as the police or lawyers for appropriate action.